Biochanin A Mitigates Oxidative Stress and Inflammation in Diabetic Myocardial Infarction: Insights From a Streptozotocin and Isoproterenol Rat Model
Authors:
Open Access
- 30 March 2025
- journal article
- Published by Springer Nature in Cureus
- Vol. 17 (3) , e81455
Abstract
Introduction: Diabetes mellitus (DM) significantly increases the risk and severity of myocardial infarction (MI), contributing to poor cardiovascular outcomes through oxidative stress, inflammation, and endothelial dysfunction. Methods: This study evaluates the cardioprotective potential of biochanin A (BCA), a naturally occurring isoflavonoid with antioxidant and anti-inflammatory properties, in a streptozotocin (STZ) and isoproterenol (ISO)-induced model of diabetic myocardial infarction (DMI) in rats. Male Wistar rats were divided into five groups, including normal controls, STZ+ISO, and three BCA-treated groups (5, 10, and 20 mg/kg). Results: BCA administration significantly improved electrocardiographic parameters by reducing ST height and QT interval prolongation (p < 0.05). It also reduced myocardial injury markers (lactate dehydrogenase (LDH), creatinine kinase on myocardial bundle (CK-MB), aspartate transaminase (AST), and cardiac troponin-T (cTn-T)) in a dose-dependent manner (p < 0.001). BCA normalized blood pressure, heart rate, and left ventricular function, improving maximum and minimum rate of ventricular contraction (+dP/dt, -dP/dt) (p < 0.01). Furthermore, BCA significantly decreased blood glucose levels and improved lipid profiles by lowering total cholesterol (TC), triglycerides (TG), and low-density lipoprotein (LDL) while increasing high-density lipoprotein (HDL) levels (p < 0.001). It suppressed inflammation by reducing tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β levels (p < 0.01). Oxidative stress markers, including malondialdehyde (MDA), were reduced, while antioxidant markers such as glutathione (GSH), superoxide dismutase (SOD), and catalase were increased (p < 0.001). BCA enhanced nuclear factor erythroid 2-related factor 2 (Nrf2) expression, promoting antioxidant defense. Histopathological analysis confirmed reduced myocardial injury and improved cardiac architecture. Conclusion: These findings highlight BCA’s potential as a therapeutic agent for managing DMI through its dual antioxidant and anti-inflammatory actions.Keywords
This publication has 29 references indexed in Scilit:
- Sustained release of nano-encapsulated glimepiride drug with chitosan nanoparticles: A novel approach to control type 2 diabetes in streptozotocin-induced Wistar albino ratsInternational Journal of Biological Macromolecules, 2024
- The isoproterenol-induced myocardial fibrosis: A biochemical and histological investigationBiomedicine & Pharmacotherapy, 2024
- Punicalagin attenuates myocardial oxidative damage, inflammation, and apoptosis in isoproterenol-induced myocardial infarction in rats: Biochemical, immunohistochemical, and in silico molecular docking studiesChemico-Biological Interactions, 2023
- Ruthenium biochanin-A complex ameliorates lung carcinoma through the downregulation of the TGF-β/PPARγ/PI3K/TNF-α pathway in association with caspase-3-mediated apoptosisToxicological Research, 2023
- Neuroprotective potential of biochanin-A and review of the molecular mechanisms involvedMolecular Biology Reports, 2023
- Biochanin‐A has antidiabetic, antihyperlipidemic, antioxidant, and protective effects on diabetic nephropathy via suppression of TGF‐β1 and PAR‐2 genes expression in kidney tissues of STZ‐induced diabetic ratsBiotechnology and Applied Biochemistry, 2021
- Sumatriptan protects against myocardial ischaemia–reperfusion injury by inhibition of inflammation in rat modelInflammopharmacology, 2019
- Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular MechanismsCanadian Journal of Cardiology, 2018
- An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathyInternational Journal of Cardiology, 2013
- Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar ratsEuropean Journal of Pharmacology, 2011